Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Carisma Therapeutics Inc CARM

Healthcare Biotechnology
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing its proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. It is developing a pipeline of product candidates, with an initial focus on advancing multiple ex vivo autologous and in vivo CAR-M therapies for the... see more

Recent & Breaking News (NDAQ:CARM)

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sesen Bio, Inc. (SESN)

PR Newswire September 1, 2021

CLASS ACTION UPDATE for DIDI, ARDX and SESN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 1, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATVI, ATIP and SESN

Accesswire September 1, 2021

Pomerantz Law Firm Announces the Filing of a Class Action Against Sesen Bio, Inc. and Certain Officers - SESN

PR Newswire August 31, 2021

DEADLINE: Sesen Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Sesen Bio Class Action Lawsuit - SESN

Newsfile August 31, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile August 31, 2021

CLASS ACTION UPDATE for CRMD, SESN and HYRE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire August 31, 2021

Sesen Bio, Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Sesen Bio, Inc.

PR Newswire August 31, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ITRM, ANVS and SESN

Accesswire August 31, 2021

Lawsuits Filed Against PLL, KPLT and SESN - Jakubowitz Law Pursues Shareholders Claims

Accesswire August 30, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile August 30, 2021

SESN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Sesen Bio, Inc. Limited Shareholders

Newsfile August 30, 2021

SESN INVESTOR NEWS: ROSEN, A TOP RANKED LAW FIRM, Encourages Sesen Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SESN

PR Newswire August 29, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile August 29, 2021

Sesen Update

Newsfile August 29, 2021

Sesen Class Action Reminder

Newsfile August 27, 2021

SESN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Sesen Bio, Inc. Limited Shareholders

Newsfile August 27, 2021

SESN: Berman Tabacco Alerts Investors with Losses Over $50,000 from Investments in Sesen Bio, Inc. of Upcoming Lead Plaintiff Deadline

Newsfile August 27, 2021

SESN Investor Alert: Rosen, Global Investor Counsel, Encourages Sesen Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SESN

Newsfile August 27, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile August 27, 2021